Eisler Capital (Uk) Ltd. Merck & Co., Inc. Call Options Transaction History

Eisler Capital (Uk) Ltd.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $5.52 Million - $6.4 Million	49,636 Added 27.33%	231,263 $26.3 Million
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $6.88 Million - $7.39 Million	55,596 Added 44.11%	181,627 $22.5 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $2.68 Million - $3.12 Million	23,632 Added 23.08%	126,031 $16.6 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $5.58 Million - $6.07 Million	55,711 Added 119.33%	102,399 $11.2 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $4.81 Million - $5.34 Million	46,688 New	46,688 $4.81 Million

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.